Dr Reddy's Lab rebounds 5% from intra-day's low

The stock moved higher by 2% to Rs 3,213, bouncing back 5% from intra-day's low of Rs 3,057 on NSE.

SI Reporter Mumbai
Last Updated : Dec 17 2014 | 12:19 PM IST
Dr Reddy’s Laboratories has moved higher by 2% to Rs 3,213, bouncing back 5% from intra-day’s low on the National Stock Exchange (NSE).

The stock hit a low of Rs 3,057 in early morning trade, after 6.4% yesterday’s fall, on fear that a crash of the Russian currency would hurt the exports of the company.

However, analyst at Angel Broking belives that it’s unlikely to have much impact on the profitability of the company, as the company derives only 15% of its sales (in FY2014) from the Russia and other markets in the region.

“The company had posted a dip of 13% from the region, on back of the same in 2QFY2015. Thus, in all possibility the 3QFY2015 numbers could be impacted on back on back of the same, however given that the movement has been very volatile and that the Russian government will take steps like hiking interest rates and others to safe guard their economy and thus we believe that the plunge could be arrested and should not impact the FY2016 numbers,” analyst said in a client note.

Moreover, the company is expected to post a robust growth on back of the new product launches in US (which constitutes around 45% of sales in FY2014), which will aid high profitability. Thus net-net we don’t expects the Ruble to have a great impact on the overall profitability of the company. Thus, we maintain our buy on the stock with an upgraded price target of Rs 3,935, it added.
 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 17 2014 | 12:16 PM IST

Next Story